ArticleJournal of experimental & clinical cancer research : CR2026

Psammaplysene D overcomes sorafenib resistance in liver cancer by targeting FGFR4/CYP26A1-retinoic acid axis to drive ferroptosis.

Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.